Titanium dioxide Completed Phase 2 Trials for Advanced Malignant Neoplasm / Dermatologic Complications Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT01867294Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab